Effects of 5,10-Dideazatetrahydrofolic Acid on Ovarian Cancer Cells
Author Information
Author(s): E. Erbal, S. Sen, C. Sessa, F.L. Vikhanskaya, M. D'Incalci
Primary Institution: Istituto di Ricerche Farmacologiche 'Mario Negri'
Hypothesis
How does 5,10-dideazatetrahydrofolic acid (DDATHF) affect the cell cycle and DNA integrity of ovarian cancer cells?
Conclusion
The study shows that DDATHF's cytotoxicity is modulated by folic and folinic acid concentrations.
Supporting Evidence
- DDATHF treatment inhibited the clonogenic potential of ovarian cancer cells.
- Folic acid concentration in the medium significantly affected DDATHF cytotoxicity.
- Folinic acid could completely rescue cells when given simultaneously with DDATHF.
Takeaway
This study looks at how a cancer drug affects ovarian cancer cells and how certain vitamins can change its effects.
Methodology
The SW626 human ovarian carcinoma cell line was treated with DDATHF and various concentrations of folic and folinic acid to assess cytotoxic effects and cell cycle changes.
Limitations
The study was conducted in vitro, which may not fully represent in vivo conditions.
Want to read the original?
Access the complete publication on the publisher's website